# Bioequivalence Study of Two Formulations of Febuxostat 120 mg Film-coated Tablets in Healthy Adult Volunteers After a Single Oral Dose Administration Under Fasting Conditions

> **NCT03918551** · PHASE1 · COMPLETED · sponsor: **Pharmtechnology LLC** · enrollment: 50 (actual)

## Conditions studied

- Bioequivalence

## Interventions

- **DRUG:** Febuxostat
- **DRUG:** Adenuric

## Key facts

- **NCT ID:** NCT03918551
- **Lead sponsor:** Pharmtechnology LLC
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-05-03
- **Primary completion:** 2019-06-06
- **Final completion:** 2019-06-06
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2019-07-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03918551

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03918551, "Bioequivalence Study of Two Formulations of Febuxostat 120 mg Film-coated Tablets in Healthy Adult Volunteers After a Single Oral Dose Administration Under Fasting Conditions". Retrieved via AI Analytics 2026-06-12 from https://api.ai-analytics.org/clinical/NCT03918551. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*